(2025, June 6)
Given the observed increased risk of colorectal cancer among patients receiving GLP-1 receptor agonists, clinicians should approach long-term prescribing of these agents with careful consideration, particularly in individuals with additional risk factors for colorectal cancer, such as a family history, obesity, inflammatory bowel disease, or long-standing type 2 diabetes
The first randomized, double-blind, placebo-controlled trial using liraglutide after MBS was performed by Lofton et al
UK Guidance Many new mothers wonder whether they can take Wegovy whilst breastfeeding to support postpartum weight management
If you have either type, you may end up having to have surgery to remove part of your liver or get a liver transplant
In September, Doustdar announced that the company would cut 11% of its 78,400 global workforce in an effort to cut costs